Vanguard Group’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-3,377,132
Closed -$421M 3961
2013
Q3
$421M Sell
3,377,132
-612,931
-15% -$77.6M 0.04% 501
2013
Q2
$346M Buy
+3,990,063
New +$367M 0.04% 541

Vanguard Group's ONXX Position: Q4 2013 in Review

Vanguard Group sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 3,377,132 shares — an estimated $421M sold.

Vanguard Group first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $421M in Q3 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • Vanguard Group reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Vanguard Group sold 3,377,132 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $421M.
  • Vanguard Group first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Vanguard Group's ONYX PHARMACEUTICALS INC position peaked at $421M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on Vanguard Group's 13F filing for Q4 2013, filed 12 Feb 2014.